Aker Christopher Ray - Insider Non-Derivative Transactions at Regulus Therapeutics Inc. (RGLS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 18, 2024, Aker Christopher Ray's relationship to Regulus Therapeutics Inc. (RGLS) is Officer (Sr. VP & General Counsel), and currently has 10,056 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RGLS insiders.
Data Source: SEC.
Aker Christopher Ray - Insider Non-Derivative Transactions of RGLS Common Stock
Aker Christopher Ray - Insider Non-Derivative Transactions at RGLS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 19, 2024 | Sell -- (Common Stock) | 5468 | 1.19 | 10056 |
| Jan 13, 2024 | Acquisition -- (Common Stock) | 11250 | 0 | 15524 |